Abstract

Case Report

Resolution of Chronic Bacterial Prostatitis with Bacteriophage-antibiotic Therapy

Lia Nadareishvili, Lasha Mchedlishvili, Nata Nakaidze*, Mariam Dadiani, Dea Nizharadze and Mzia Kutateladze

Published: 22 August, 2024 | Volume 8 - Issue 2 | Pages: 026-030

Chronic bacterial prostatitis is a commonly diagnosed genitourinary infection that presents significant challenges both in diagnosis and treatment. In an upcoming era of antibiotic resistance, and limited therapeutic options it becomes imperative to revise current guidelines and to provide more effective treatment strategies. At the Eliava Phage Therapy Center (Tbilisi, Georgia) we utilize bacteriophage therapy as an alternative approach against chronic bacterial infections. Bacteriophages, viruses that target and lyse specific bacterial cells, can be used as a stand-alone treatment or in conjunction with antibiotics. We present a case report of a patient with prostatitis caused by Escherichia coli infection, who prior to addressing our clinic, has been receiving antibiotic therapy without any positive effect. Our approach of combined use of antibiotics and phages was successful not only in complete clinical improvement but also in total bacterial eradication. This outcome shows the potential of bacteriophage therapy as a valuable adjunct to conventional antibacterials in the management of prostatitis.

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001059 Cite this Article Read Full Article PDF

References

  1. Holt JD, Garrett WA, McCurry TK, Teichman JM. Common questions about chronic prostatitis. Am Fam Physician. 2016; 93(4):290-296. Available from: https://pubmed.ncbi.nlm.nih.gov/26926816/
  2. Vaidyanathan R, Mishra VC. Chronic prostatitis: Current concepts. Indian J Urol. 2008; 24(1):22-27. Available from: https://doi.org/10.4103%2F0970-1591.38598
  3. Meyrier A, Fekete T. Chronic bacterial prostatitis. UpToDate. 2023.
  4. Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, et al. Comprehensive overview of prostatitis. Biomed Pharmacother. 2017; 94:1064-1076. Available from: https://doi.org/10.1016/j.biopha.2017.08.016
  5. Stamatiou KN, Moschouris H. A prospective interventional study in chronic prostatitis with emphasis to clinical features. Urol J. 2014; 11(4):1829-1833. Available from: https://pubmed.ncbi.nlm.nih.gov/25194085/
  6. McNaughton Collins M, Pontari MA, O'Leary MP, Calhoun EA, Santanna J, Landis JR, et al. Chronic Prostatitis Collaborative Research Network. Quality of life is impaired in men with chronic prostatitis: The Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001; 16(10):656-662. Available from: https://doi.org/10.1111/j.1525-1497.2001.01223.x
  7. Heras-Cañas V, Gutiérrez-Soto B, Serrano-García ML, Vázquez-Alonso F, Navarro-Marí JM, Gutiérrez-Fernández J. Prostatitis crónica bacteriana. Estudio clínico y microbiológico de 332 casos. Med Clin (Barc). 2016; 147(4):144-147. Available from: https://doi.org/10.1016/j.medcli.2016.05.018
  8. Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, et al. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents. 2006; 28 Suppl 1. Available from: https://doi.org/10.1016/j.ijantimicag.2006.05.006
  9. Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010; 50(12):1641-1652. Available from: https://doi.org/10.1086/652861
  10. Duclos AJ, Lee CT, Shoskes DA. Current treatment options in the management of chronic prostatitis. Ther Clin Risk Manag. 2007; 3(4):507-512. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374945/
  11. Trinchieri A, Abdelrahman KM, Bhatti KH, Bello JO, Das K, Gatsev O, et al. Spectrum of causative pathogens and resistance rates to antibacterial agents in bacterial prostatitis. Diagnostics (Basel). 2021; 11(8):1333. Available from: https://www.mdpi.com/2075-4418/11/8/1333#
  12. Letkiewicz S, Międzybrodzki R, Kłak M, Jończyk E, Weber-Dąbrowska B, Górski A. The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunol Med Microbiol. 2010; 60(2):99-112. Available from: https://doi.org/10.1111/j.1574-695x.2010.00723.x
  13. Johri AV, Johri P, Hoyle N, Nadareishvili L, Pipia L, Nizharadze D. Case report: Successful treatment of recurrent coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis. Front Pharmacol. 2023; 14:1243824. Available from: https://doi.org/10.3389%2Ffphar.2023.1243824
  14. Stevens RH, Zhang H, Kajsik M, Płoski R, Rydzanicz M, Sabaka P, Šutovský S. Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis. Front Med (Lausanne). 2023; 10:1238147. Available from: https://doi.org/10.3389%2Ffmed.2023.1238147
  15. Leitner L, Sybesma W, Chanishvili N, Goderdzishvili M, Chkhotua A, Ujmajuridze A, et al. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomized, placebo-controlled, double-blind clinical trial. BMC Urol. 2017; 17(1):90. Available from: https://doi.org/10.1016/s1473-3099(20)30330-3
  16. Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J, et al. Phage therapy in prostatitis: Recent prospects. Front Microbiol. 2018; 9:1434. Available from: https://doi.org/10.3389%2Ffmicb.2018.01434
  17. Ferriol-González C, Domingo-Calap P. Phages for biofilm removal. Antibiotics (Basel). 2020; 9(5):268. Available from: https://doi.org/10.3390/antibiotics9050268
  18. Li X, He Y, Wang Z, Wei J, Hu T, Si J, et al. A combination therapy of phages and antibiotics: Two is better than one. Int J Biol Sci. 2021; 17(13):3573-3582. Available from: https://doi.org/10.7150%2Fijbs.60551
  19. Nickel JC. Classification and diagnosis of prostatitis: A gold standard? Andrologia. 2003; 35(3):160-167. Available from: https://doi.org/10.1046/j.1439-0272.2003.00557.x
  20. Mobley DF. Semen cultures in the diagnosis of bacterial prostatitis. J Urol. 1975; 114(1):83-85. Available from: https://doi.org/10.1016/s0022-5347(17)66949-0
  21. Valério N, Oliveira C, Jesus V, Branco T, Pereira C, Moreirinha C, et al. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli. Virus Res. 2017; 240:8-17. Available from: https://doi.org/10.1016/j.virusres.2017.07.015
  22. Łusiak-Szelachowska M, Międzybrodzki R, Drulis-Kawa Z, Cater K, Knežević P, Winogradow C, et al. Bacteriophages and antibiotic interactions in clinical practice: What we have learned so far. J Biomed Sci. 2022; 29(1):23. Available from: https://doi.org/10.1186/s12929-022-00806-1
  23. Malik S, Nehra K, Rana JS. Bacteriophage cocktail and phage-antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli. Virus Res. 2021; 302:198496. Available from: https://doi.org/10.1016/j.virusres.2021.198496
  24. Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J. Biofilm formation in uropathogenic Escherichia coli strains: Relationship with prostatitis, urovirulence factors, and antimicrobial resistance. J Urol. 2007; 177(1):365-368. Available from: https://doi.org/10.1016/j.juro.2006.08.081
  25. Mazzoli S. Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol. 2010; 59(3):337-344. Available from: https://doi.org/10.1111/j.1574-695x.2010.00659.x
  26. Azeredo J, García P, Drulis-Kawa Z. Targeting biofilms using phages and their enzymes. Curr Opin Biotechnol. 2021; 68:251-261. Available from: https://doi.org/10.1016/j.copbio.2021.02.002
  27. Tagliaferri TL, Jansen M, Horz HP. Fighting pathogenic bacteria on two fronts: Phages and antibiotics as a combined strategy. Front Cell Infect Microbiol. 2019; 9:22. Available from: https://doi.org/10.3389%2Ffcimb.2019.00022
  28. Ackerman AL, Chai TC. The bladder is not sterile: An update on the urinary microbiome. Curr Bladder Dysfunct Rep. 2019;14(4):331-341. Available from: https://doi.org/10.1007/s11884-019-00543-6
  29. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, et al. Urine is not sterile: Use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014; 52(3):871-876. Available from: https://doi.org/10.1128%2FJCM.02876-13
  30. Schneeweiss J, Koch M, Umek W. The human urinary microbiome and how it relates to urogynecology. Int Urogynecol J. 2016; 27(9):1307-1312. Available from: https://doi.org/10.1007/s00192-016-2944-5
  31. Miller-Ensminger T, Garretto A, Brenner J, Thomas-White K, Zambom A, Wolfe AJ, et al. Bacteriophages of the urinary microbiome. J Bacteriol. 2018; 200(7). Available from: https://doi.org/10.1128%2FJB.00738-17

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?